Anticoccidial Drugs Market is one of the common poultry disease, which is caused by the parasite called as coccidian protozoa. It is highly resistant to harsh, rough environment and disinfectants. Anticoccidial Drugs Market exists in the intestinal tract and undergoes multiplication to cause damage to the tissues, in turn, impede with the absorption of nutrients and digestion of food that may lead to the dehydration of body and blood loss. Damaging of tissue in the animal may make the bird more infection prone to bacteria such as salmonella and clostridia. The disease transfers from one to other by contact with infected litter, faeces or damaged tissue. Coccidiosis is prevented by maintaining litter management and proper sanitation. Anticoccidial medications are used in conventional animal feeding, which is usually added to animal feed for prevention of coccidiosis. Rising Population pool, stability in economic conditions are leading to the rise in demand for foods with rich proteins, especially in the developing nations. Companies in veterinary healthcare were well established for addressing the growth of emerging markets towards the demand for the high-protein diets. Continuous investments for the innovations and the technological advancements for the development of animal health drugs. In 2015, Elililly acquired Novartis Animal Health to expand its Elanco Animal Health Unit in various product portfolios. In 2014 November, Zoetis Inc. has reintroduction its Zoamix (zoalene) in the USA, which is a synthetic anticoccidial drug used to control and prevent coccidiosis in poultry production. In 2011, Ceva Sante Animale acquired vetech laboratories a Canadian producer of live vaccines and drugs for coccidiasis to expand its product portfolio.